May 26
|
3 of Wall Street’s Favorite Stocks with Mounting Challenges
|
May 23
|
Insiders Pour Millions into These 3 Stocks — Here’s Why They Draw Plaudits Across the Board
|
Apr 23
|
Jazz Pharmaceuticals Showcases Transformative Data at ASCO 2025, Highlighting Advances in Small Cell Lung Cancer, HER2+ Gastroesophageal Cancer and Diffuse Glioma
|
Apr 23
|
Buy 5 High ROE Stocks as Markets Break Tariff-Induced Losing Streak
|
Apr 23
|
3 Small-Cap Stocks in the Doghouse
|
Apr 22
|
Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025
|
Apr 21
|
Jazz Pharmaceuticals Completes Acquisition of Chimerix
|
Apr 21
|
JAZZ vs. HRMY: Which Neuroscience Drugmaker Is the Stronger Play?
|
Apr 17
|
JAZZ vs. ARGX: Which Stock Is the Better Value Option?
|
Apr 17
|
Is Jazz Pharmaceuticals a Top Cannabis Investment for 2025?
|
Apr 17
|
Pharmaceuticals Stocks Q4 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers
|
Mar 14
|
JAZZ or ILMN: Which Is the Better Value Stock Right Now?
|
Mar 14
|
Will Auvelity & Other Drugs Aid AXSM's Growth Amid Stiff Competition?
|
Mar 14
|
Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Value Stock
|
Mar 12
|
BIIB Starts Felzartamab Phase III Study in AMR in Kidney Transplant
|
Mar 12
|
Jazz Pharmaceuticals and Boston Beer Company have been highlighted as Zacks Bull and Bear of the Day
|
Mar 12
|
Bull of the Day: Jazz Pharmaceuticals (JAZZ)
|
Mar 10
|
4 Discounted PEG Stocks Offering the Best Returns to Value Investors
|
Mar 9
|
Why Chimerix, Inc. (CMRX) Soared Last Week
|
Mar 3
|
Jazz Pharmaceuticals plc (JAZZ): Among the Cash-Rich Mid Cap Stocks to Buy Now
|